Biggest News Aggregation in the World
๐Ÿ“ฐ Patient Support Program News

Page 2 - Patient Support Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Patient Support Program. Real-time updates on events, politics, business and more.

FDA Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma -November 16, 2023 at 05:41 pm EST

Approval based on results from the Phase 3 KEYNOTE-859 trial, which demonstrated significant improvement in overall survival in these patients versus chemotherapy alone Approval marks seventh...
United States Statement Of Merck Co Inc Drug Administration Exchange Commission Patient Support Program Merck Access Program

Celltrion USA has signed a contract with Ventegra® to add Yuflyma® (adalimumab-aaty) as a preferred

- By inclusion in Ventegraโ€™s formularies, Yuflyma® has secured access through the appropriate channel for about 3.6% of the U.S. populationJERSEY CITY, N.J.--(BUSINESS WIRE)--Celltrion USA has signed a contract with Ventegra ®, a major U.S. Medical Benefits Manager (MBM) who administers pharmacy benefits through its...
New Jersey United States Thomas Nusbickel Francine Galante Robertt Taketomo Pharmacy Services Administrator

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve access and affordability for patients and the US health care system
Jersey City New Jersey United States Christopher Hansung Ko Kevin Ali Samsung Bioepis

REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd)

Autoinjector recognized by the Arthritis Foundation with Ease of Use CertificationIndividualized patient support program โ€œHADLIMA For Youโ€ available including co-pay supportDesigned to improve access and affordability for patients and the US health care systemJERSEY CITY, N.J. & INCHEON, Korea--(BUSINESS WIRE)--Orga...
Jersey City New Jersey United States Christopher Hansung Ko Kevin Ali Samsung Bioepis

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science